• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态诊断方法推进肌肉减少症和衰弱症的精准医学

Multimodal Diagnostic Approaches to Advance Precision Medicine in Sarcopenia and Frailty.

机构信息

Division of Geriatric Medicine, Center for Aging and Health, University of North Carolina, Chapel Hill, NC 27599, USA.

Division of Medicine and Pediatrics, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Nutrients. 2022 Mar 26;14(7):1384. doi: 10.3390/nu14071384.

DOI:10.3390/nu14071384
PMID:35405997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9003228/
Abstract

Sarcopenia, defined as the loss of muscle mass, strength, and function with aging, is a geriatric syndrome with important implications for patients and healthcare systems. Sarcopenia increases the risk of clinical decompensation when faced with physiological stressors and increases vulnerability, termed frailty. Sarcopenia develops due to inflammatory, hormonal, and myocellular changes in response to physiological and pathological aging, which promote progressive gains in fat mass and loss of lean mass and muscle strength. Progression of these pathophysiological changes can lead to sarcopenic obesity and physical frailty. These syndromes independently increase the risk of adverse patient outcomes including hospitalizations, long-term care placement, mortality, and decreased quality of life. This risk increases substantially when these syndromes co-exist. While there is evidence suggesting that the progression of sarcopenia, sarcopenic obesity, and frailty can be slowed or reversed, the adoption of broad-based screening or interventions has been slow to implement. Factors contributing to slow implementation include the lack of cost-effective, timely bedside diagnostics and interventions that target fundamental biological processes. This paper describes how clinical, radiographic, and biological data can be used to evaluate older adults with sarcopenia and sarcopenic obesity and to further the understanding of the mechanisms leading to declines in physical function and frailty.

摘要

肌肉减少症是一种以肌肉质量、力量和功能随年龄增长而下降为特征的老年综合征,对患者和医疗保健系统都有重要影响。肌肉减少症增加了患者在面对生理压力时临床失代偿的风险,并增加了脆弱性,即虚弱。肌肉减少症是由于生理和病理衰老引起的炎症、激素和肌细胞变化引起的,这些变化促进了脂肪量的增加和瘦体重和肌肉力量的损失。这些病理生理变化的进展可导致肌肉减少性肥胖和身体虚弱。这些综合征独立增加了不良患者结局的风险,包括住院、长期护理安置、死亡和生活质量下降。当这些综合征共存时,风险会大大增加。虽然有证据表明肌肉减少症、肌肉减少性肥胖和虚弱的进展可以减缓或逆转,但广泛筛查或干预措施的采用实施缓慢。导致实施缓慢的因素包括缺乏具有成本效益的、及时的床边诊断和针对基本生物学过程的干预措施。本文描述了如何使用临床、影像学和生物学数据来评估患有肌肉减少症和肌肉减少性肥胖的老年人,并进一步了解导致身体功能下降和虚弱的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/7febce5ee869/nutrients-14-01384-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/7d5ce18ea880/nutrients-14-01384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/2f3053130478/nutrients-14-01384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/7febce5ee869/nutrients-14-01384-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/7d5ce18ea880/nutrients-14-01384-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/2f3053130478/nutrients-14-01384-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b34a/9003228/7febce5ee869/nutrients-14-01384-g003.jpg

相似文献

1
Multimodal Diagnostic Approaches to Advance Precision Medicine in Sarcopenia and Frailty.多模态诊断方法推进肌肉减少症和衰弱症的精准医学
Nutrients. 2022 Mar 26;14(7):1384. doi: 10.3390/nu14071384.
2
Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges.肠促胰岛素疗法时代的肌少症性肥胖治疗:观点与挑战
Diabetes. 2025 Jul 11. doi: 10.2337/dbi25-0004.
3
Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR).关于促进老年人健康长寿的最佳运动建议的全球共识(国际功能、健康与老龄化研究学会)
J Nutr Health Aging. 2025 Jan;29(1):100401. doi: 10.1016/j.jnha.2024.100401. Epub 2025 Jan 1.
4
The effect of Tai Chi in elderly individuals with sarcopenia and frailty: A systematic review and meta-analysis of randomized controlled trials.太极拳对伴有肌少症和衰弱的老年人的影响:系统评价和随机对照试验的荟萃分析。
Ageing Res Rev. 2022 Dec;82:101747. doi: 10.1016/j.arr.2022.101747. Epub 2022 Oct 9.
5
MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review.肥胖症、肌肉减少症及二者共病的 microRNAs:系统综述。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):68-85. doi: 10.1002/jcsm.12878. Epub 2022 Jan 4.
6
The Diagnosis and Treatment of Sarcopenia and Sarcopenic Obesity.肌少症和肌少症肥胖症的诊断与治疗
Dtsch Arztebl Int. 2025 Mar 7;122(5):121-126. doi: 10.3238/arztebl.m2025.0004.
7
Vascular endothelial dysfunction may be an early predictor of physical frailty and sarcopenia: A meta-analysis of available data from observational studies.血管内皮功能障碍可能是身体虚弱和肌肉减少症的早期预测指标:来自观察性研究的现有数据的荟萃分析。
Exp Gerontol. 2021 Jun;148:111260. doi: 10.1016/j.exger.2021.111260. Epub 2021 Feb 8.
8
Association of Sarcopenic Obesity and Osteoporosis in Postmenopausal Women: Risk Factors and Protective Effects of Hormonal Therapy and Nutritional Status.绝经后女性肌少性肥胖与骨质疏松症的关联:激素治疗和营养状况的风险因素及保护作用
Arch Osteoporos. 2025 Jun 26;20(1):83. doi: 10.1007/s11657-025-01573-w.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
Systemic Inflammatory Response Syndrome全身炎症反应综合征

引用本文的文献

1
The Critical Role of Body Composition Assessment in Advancing Research and Clinical Health Risk Assessment across the Lifespan.身体成分评估在推进全生命周期研究及临床健康风险评估中的关键作用。
J Obes Metab Syndr. 2025 Apr 30;34(2):120-137. doi: 10.7570/jomes25010. Epub 2025 Apr 8.
2
Fat-Free Mass: Friend or Foe to Metabolic Health?去脂体重:代谢健康的朋友还是敌人?
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13714. doi: 10.1002/jcsm.13714.
3
Negative Lifestyle Factors Specific to Aging Persons Living with HIV and Multimorbidity.

本文引用的文献

1
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.定义和诊断肌少症性肥胖的标准:ESPEN 和 EASO 共识声明。
Obes Facts. 2022;15(3):321-335. doi: 10.1159/000521241. Epub 2022 Feb 23.
2
Multi-omics research in sarcopenia: Current progress and future prospects.肌肉减少症的多组学研究:当前进展与未来展望。
Ageing Res Rev. 2022 Apr;76:101576. doi: 10.1016/j.arr.2022.101576. Epub 2022 Jan 29.
3
Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity.内皮细胞 Piezo1 维持肌肉毛细血管密度,并有助于身体活动。
特定于老年 HIV 合并多种疾病患者的负面生活方式因素。
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241245228. doi: 10.1177/23259582241245228.
4
Exploring the complex associations among risks of malnutrition, sarcopenia, and frailty in community-dwelling older adults.探究社区居住老年人中营养不良、肌肉减少症和衰弱风险之间的复杂关联。
Eur Rev Aging Phys Act. 2024 Jul 9;21(1):18. doi: 10.1186/s11556-024-00354-7.
5
Effects of Bariatric Surgery on Sarcopenic Obesity Outcomes: A One-Year Prospective Study in Middle-Aged Women.减重手术对肌肉减少性肥胖结局的影响:一项中年女性为期一年的前瞻性研究。
Obes Surg. 2024 May;34(5):1674-1683. doi: 10.1007/s11695-024-07164-x. Epub 2024 Mar 25.
6
Changes in Weight or Body Composition by Frailty Status: A Pilot Study.衰弱状态下体重或身体成分的变化:一项试点研究。
J Nutr Gerontol Geriatr. 2024 Apr-Jun;43(2):83-94. doi: 10.1080/21551197.2024.2326807. Epub 2024 Mar 12.
7
Development of a predictive score for post-hemithyroidectomy hypothyroidism using skeletal muscle index, remnant thyroid index, and thyroid-stimulating hormone levels: a retrospective cohort study.利用骨骼肌指数、残余甲状腺指数和促甲状腺激素水平制定甲状腺半切术后甲状腺功能减退的预测评分:一项回顾性队列研究
Quant Imaging Med Surg. 2023 Sep 1;13(9):5525-5535. doi: 10.21037/qims-23-53. Epub 2023 Jul 7.
8
Baseline Serum Biomarkers Predict Response to a Weight Loss Intervention in Older Adults with Obesity: A Pilot Study.基线血清生物标志物预测肥胖老年人对减肥干预的反应:一项试点研究。
Metabolites. 2023 Jul 17;13(7):853. doi: 10.3390/metabo13070853.
9
Effects of Exercise Training on Muscle Quality in Older Individuals: A Systematic Scoping Review with Meta-Analyses.运动训练对老年人肌肉质量的影响:一项荟萃分析的系统综述
Sports Med Open. 2023 Jun 6;9(1):41. doi: 10.1186/s40798-023-00585-5.
10
Fiber-Type Shifting in Sarcopenia of Old Age: Proteomic Profiling of the Contractile Apparatus of Skeletal Muscles.衰老性肌肉减少症中的纤维类型转变:骨骼肌收缩装置的蛋白质组学分析。
Int J Mol Sci. 2023 Jan 26;24(3):2415. doi: 10.3390/ijms24032415.
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI141775.
4
Identification of traumatic acid as a potential plasma biomarker for sarcopenia using a metabolomics-based approach.采用基于代谢组学的方法鉴定创伤性酸作为肌少症的潜在血浆生物标志物。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):276-286. doi: 10.1002/jcsm.12895. Epub 2021 Dec 22.
5
Muscle-to-fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity.肌肉-脂肪比值可识别功能障碍和心血管代谢风险,并预测结局:肌少症性肥胖的生物标志物。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):368-376. doi: 10.1002/jcsm.12877. Epub 2021 Dec 5.
6
Application of ultrasound for muscle assessment in sarcopenia: towards standardized measurements.超声在肌肉减少症肌肉评估中的应用:迈向标准化测量
Eur Geriatr Med. 2018 Dec;9(6):739-757. doi: 10.1007/s41999-018-0104-9. Epub 2018 Sep 17.
7
Quantity versus quality: Age-related differences in muscle volume, intramuscular fat, and mechanical properties in the triceps surae.数量与质量:跟年龄相关的三腿头肌的肌肉量、肌内脂肪和机械性能的差异。
Exp Gerontol. 2021 Dec;156:111594. doi: 10.1016/j.exger.2021.111594. Epub 2021 Oct 18.
8
Sarcopenic metabolomic profile reflected a sarcopenic phenotype associated with amino acid and essential fatty acid changes.肌少症代谢组学特征反映了与氨基酸和必需脂肪酸变化相关的肌少症表型。
Metabolomics. 2021 Sep 8;17(9):83. doi: 10.1007/s11306-021-01832-0.
9
The physical frailty syndrome as a transition from homeostatic symphony to cacophony.身体虚弱综合征是从体内平衡交响乐向不和谐音的转变。
Nat Aging. 2021 Jan;1(1):36-46. doi: 10.1038/s43587-020-00017-z. Epub 2021 Jan 14.
10
Wearable Movement Sensors for Rehabilitation: From Technology to Clinical Practice.可穿戴运动传感器在康复中的应用:从技术到临床实践。
Sensors (Basel). 2021 Jul 12;21(14):4744. doi: 10.3390/s21144744.